Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that partly evade neutralizing antibodies raises concerns of reduced vaccine effectiveness and increased infection. We previously demonstrated that the SARS-CoV-2 spike protein vaccine adjuvanted with AS03 (CoV2 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavot, Vincent, Berry, Catherine, Kishko, Michael, Anosova, Natalie G., Huang, Dean, Tibbitts, Tim, Raillard, Alice, Gautheron, Sylviane, Gutzeit, Cindy, Koutsoukos, Marguerite, Chicz, Roman M., Lecouturier, Valerie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971430/
https://www.ncbi.nlm.nih.gov/pubmed/35361754
http://dx.doi.org/10.1038/s41467-022-29219-2

Ejemplares similares

Ejemplares similares